Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-10-24
1999-09-28
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514220, 514221, 514315, 514403, A61K 3800, A61K 3155, A61K 31445, A61K 31415
Patent
active
059588810
ABSTRACT:
A method of inducing a temporary substantial paralysis of an area of interest in a patient undergoing a medical procedure is provided. The method involves administering a therapeutically effective amount of vasoactive intestinal peptide (VIP) admixed with a pharmaceutically acceptable carrier to a patient undergoing an endoscopy or other medical procedure.
REFERENCES:
patent: 3880826 (1975-04-01), Said
patent: 4370317 (1983-01-01), Jorgensen
patent: 4598065 (1986-07-01), Lundt
patent: 4605641 (1986-08-01), Bolin
patent: 4734400 (1988-03-01), Bolin
patent: 4822774 (1989-04-01), Ito
patent: 4835252 (1989-05-01), Musso
patent: 4939224 (1990-07-01), Musso
patent: 5055302 (1991-10-01), Laties
patent: 5681816 (1997-10-01), Korman
Anuras et al. (1978) Amer. J. Physiol., 234:E60.
Biancani et al. ((1989) Reg. Peptide Let., 1(4):6.
Bitar et al (1982) Science 216:351.
Bjorkem et al. (1990) Pediatr. Cardiol., 11:1C4.
Brook et al. (1990) New Eng. J. Medicine, 323:1173.
Bunnet et al. (1984) Clin. Endocrinol, Metab., 59:1133.
Burleigh (1990) Dig. Dis. Sci., 35(5):617.
Cohen et al. (1990) Life Sciences, 26:816.
Diamant et al. (1983) Handbook Experimental Pharm., Lefevre (ed.) 66(2):611.
Ellis et al. (1992) J. Amer. Coll. Cardiol., 19:681.
Fontain et al. (1986) Br. J. Pharmac., 89:599.
Goodman et al. (1975) The Pharmacological Basis of Therapeutics, 5.sup.th.
Ed., MacMillan (ed.), New York pp. 514-532.
Gordon et al. (1990) Arch. Int. Pharmacodyn., 305:14.
Gregerson et al. (1988) Scand. J. Gastroenterol., 23 (Supp152):42.
Grider et al. (1986) Amer. J. Physiol., 25:G40.
Grider et al (1985) Amer. J. Physiol., 248:G73-G78.
Grider, J. R. (1989) Gastroenterology, 97:1414.
Grider et al. (1990) J. Pharmacol. Expt. Therapeutics, 253(3):738.
Grider J.R. (1989) Reg. Peptide Let., 1(4):1.
Grider et al. (1990) J. Pharmacol. Exper. Therap. 253:738.
Iskandrian A.S. (1991) Amer. Heart J. 122:279.
Khalil et al. (1987) Gastrointestinal Endocrinology, J.C. Thomas (ed) McGraw Hill, New York, pp. 260-272.
Kotler et al. (1990) Ann. Intern. Med., 113:684.
Kreen L. (1975) Br. J. Radiol., 48:691.
Larsen et al. (1986) Scand. J. Gastroenterol., 21:634.
Maggi et al. (1990) Naunyn-Schmiedeberg's Arch Pharmacol., 341:256.
Manyari et al. (1986) Clin. Invest Med., 9:76.
Norfleet R.G. (1978) Gastrointestinal Endoscopy, 24:164.
Qvigstad et al. (1979) Scand. J. Gastroent. 14:231.
Roa P. S. (1989) Clin. Cardiol. 12:618.
Ross W. (1989) Gastrointestinal Endoscopy, 35(2):120.
Said et al. (1972) Euro. J. Biochem., 28:199.
Said et al. Science, 169:1217.
Siegel et al. (1979) Digest. Diseases Sci., 24(5):345.
Rae-Venter Barbara
Weddington Kevin E.
LandOfFree
Composition containing VIP for injection and a method of enhanci does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition containing VIP for injection and a method of enhanci, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition containing VIP for injection and a method of enhanci will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-703217